1
Imran et al. concluded that "The A allele of the ACE gene polymorphisms is associated with hypertension among ICH patients.
1 " We would like to share ideas on the present report. In this article, the G to A variant was found for relationship with increased risk of HT. 1 In fact, the important change due to ACE G2350A gene polymorphism is the molecular structure change. The change will result in alteration of molecular weight. Based on the molecular calculation method as published in the previous referencing studies, 2 ,3 the molecular weight change is equal to e 16 g/Mol (from in 151.13 g/ Mol in G variant to 135.13 g/Mol to A variant). Therefore, the final expression will be more difficult in G variant or ACE level will be higher in A variant. This can further imply that A variant is more related to HT due to higher ACE level. This is the same process as observed in effect of genetic polymorphisms on other medical disorders.
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Response to authors
To the Editor, This letter proposed a theoretical idea about the correlation between ACE G2350A gene polymorphism and hypertension. They revealed that ACE G2350A might affect the molecular structure changes, which had an effect on molecular weight. They also revealed that A allele had lower molecular weights than G alleles. Therefore, A allele is associated with an increased of circulating ACE levels.
We would like to thank to authors for the letter, and we are very grateful for the idea because we did not explain the idea in the discussion section of our paper. The absence of the explicit explanation regarding molecular mechanism of ACE G2350A in hypertension in our paper because, initially, we did not concern only about ACE G2350A and hypertension, but also other aggravating factors of intracerebral haemorrhage such as brain hematoma volume, level of consciousness, and disease outcome. Moreover, it was a coincidence that our results only showed a correlation between ACE G2350A and hypertension. Therefore, our paper seemed to focus on ACE G2350A and hypertension.
Theoretically, ACE G2350A has indeed been widely associated with hypertension. 2 However, there was not enough evidence (studies in human subjects) to support the correlation between ACE G2350A and hypertension. In the discussion section of our paper, 1 we compared and combined our data with other studies. Of the nine studies, the correlation was only observed in five studies, while four others failed to confirm the correlation. Moreover, the cumulative data also failed to clarify the correlation between ACE G2350A and hypertension. Therefore, for the time being, it can be concluded that the association between ACE G2350A and hypertension remains open to controversy. In the near future, we hope that there will be a meta-analysis report between ACE G2350A and hypertension by considering the adequate genetic principles and using the accurate statistical methods.
